Trader: Low Volume ...
Health Care: Drugs
A.P. Pharma Inc. (APPA: OTC)
$0.58 0.00 | 0.00%
06/04/12 - 10:32 AM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 17.97M | 2.11M | 7.59M | 9.97M |
| Receivables | 0.00 | 110.00K | 171.00K | 32.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 18.24M | 2.50M | 8.31M | 10.82M |
| Property, Plant & Equipment, Gross | 5.36M | 4.52M | 4.63M | 4.65M |
| Accumulated Depreciation & Depletion | 4.28M | 4.16M | 4.12M | 3.77M |
| Property, Plant & Equipment, Net | 1.08M | 357.00K | 510.00K | 881.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 130.00K | 53.00K | 128.00K | 103.00K |
| Total Non-Current Assets | 1.20M | 410.00K | 638.00K | 984.00K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 19.44M | 2.91M | 8.95M | 11.80M |
| Accounts Payable | 1.01M | 159.00K | 162.00K | 344.00K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 388.00K | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 3.69M | 1.56M | 1.89M | 3.19M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 35.00K | 268.00K | 1.02M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 0.00 | 35.00K | 268.00K | 1.02M |
| Total Liabilities | 3.69M | 1.60M | 2.16M | 4.20M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 15.75M | 1.32M | 6.80M | 7.60M |
| Common Par | 2.00M | 401.00K | 394.00K | 309.00K |
| Additional Paid In Capital | 173.99M | 149.34M | 147.48M | 138.38M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -160.24M | -148.42M | -141.08M | -131.05M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | -43.00K |
| Total Capitalization | 15.75M | 1.32M | 6.80M | 7.60M |
| Total Equity | 15.75M | 1.32M | 6.80M | 7.60M |
| Total Liabilities & Stock Equity | 19.44M | 2.91M | 8.95M | 11.80M |
| Total Common Shares Outstanding | 200.05M | 40.14M | 39.94M | 30.94M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 120.26M | 39.67M | 32.62M | 30.81M |
| Diluted Weighted Shares Outstanding | 120.26M | 39.67M | 32.62M | 30.81M |
| Number of Employees | 19 | 18 | 21 | 33 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with APPA
- Portfolio NameUser Type
- UserMy Folio
- Userwatchlist1
- UserMARK 1 C
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE-2709091838
- UserLatest Activist Filings 2-2...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
Latest APPA Headlines from TheStreet
- Ambac Financial, QAD: Early Volume Plays 05.18.10 | 08:05 am
- A.P. Pharma, Netlist: Early Volume Plays 03.19.10 | 10:03 am
- Biotech Stock Mailbag: Sequenom 03.12.10 | 07:03 am
- Latest News in Activist Investing 02.26.09 | 11:02 am
- Insider Action: Trading Level 3 10.03.08 | 12:10 pm
- Monday's Small-Cap Winners & Losers 06.25.07 | 04:06 pm
- Thursday's Health Winners & Losers 12.21.06 | 01:12 pm
- Monday's Small-Cap Winners & Losers 10.02.06 | 03:10 pm
Press Releases for APPA
- A.P. Pharma Announces Study Finding Continuous Exposure To A 5-HT3 Antagonist Using APF530 Provides Better Emetic Control - Business Wire 05.31.12 | 08:05 am
- A.P. Pharma Announces First Quarter 2012 Financial Results And Recent Corporate Progress - Business Wire 05.10.12 | 08:05 am
- A.P. Pharma Announces Third Quarter 2011 Financial Results And Recent Corporate Progress - Business Wire 11.07.11 | 08:11 am
- LifeSci Advisors Announces Investment Opinion On A.P. Pharma Inc. - Business Wire 08.29.11 | 01:08 pm
- A.P. Pharma Announces Second Quarter 2011 Financial Results And Reports On Recent Corporate Progress - Business Wire 08.08.11 | 08:08 am
- A.P. Pharma To Raise $24 Million In Private Placement Of Common Stock And Warrants - Business Wire 06.29.11 | 08:06 am
- A.P. Pharma Announces First Quarter 2011 Financial Results And Recent Corporate Progress - Business Wire 05.16.11 | 08:05 am
- A.P. Pharma Announces Financing Of Up To $4.5 Million And Names CEO And COO - Business Wire 04.25.11 | 08:04 am
- A.P. Pharma Provides Regulatory Update On APF530 NDA - Business Wire 04.25.11 | 08:04 am
- A.P. Pharma Announces Transfer To OTCQB - Business Wire 03.31.11 | 06:03 am
Partner Headlines for APPA
- Mannkind Slashes Staff: Biotech's Latest Tribulations - Seeking Alpha 02.13.11 | 08:02 am
- UPDATE 3-FDA denies approval of AP Pharma nausea drug; shrs sink - Reuters 03.19.10 | 12:03 pm
